Legend Biotech Overview
Legend Biotech Target Price
Where could LEGN trade next? Consensus target price: $56.
Get informed when a big investor buys or sells
+ FollowShare Price
$17.61
Average Target Price
$55.50
215.2% upside
215.2% upside10 analysts in the last 4 months
High: $78 | Low: $28
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-04 | Morgan Stanley | $65 | 269.1% upside |  |
| 2026-08-12 | Oppenheimer | $40 | 127.1% upside | |
| 2026-08-12 | Barclays | $78 | 342.9% upside | |
| 2026-07-27 | Raymond JamesSean McCutcheon | $58 | 229.4% upside | |
| 2026-07-27 | RBC Capital | $59 | 235% upside | |
| 2026-07-24 | UBS | $28 | 59% upside | |
| 2026-07-07 | RBC CapitalLeonid Timashev | $63 | 257.8% upside | |
| 2026-06-03 | UBSAshwani Verma | $49 | 178.3% upside | |
| 2026-06-03 | H.C. Wainwright | $65 | 269.1% upside | |
| 2026-06-01 | UBS | $50 | 183.9% upside | |
| 2026-05-13 | RBC CapitalLeonid Timashev | $64 | 263.4% upside | |
| 2026-05-13 | Morgan StanleyTerence Flynn | $48 | 172.6% upside | |
| 2026-03-11 | Morgan Stanley | $49 | 178.3% upside | |
| 2026-03-11 | RBC Capital | $62 | 252.1% upside | |
| 2026-03-10 | Truist FinancialAsthika Goonewardene | $70 | 297.5% upside | |
| 2026-03-10 | JefferiesCui Cui | $69 | 291.8% upside | |
| 2026-02-12 | Redburn PartnersQize Ding | $24 | 36.3% upside | |
| 2026-01-22 | H.C. Wainwright | $50 | 183.9% upside | |
| 2026-01-22 | Jefferies | $21 | 19.3% upside | |
| 2026-01-20 | RBC Capital | $66 | 274.8% upside | |
| 2026-01-07 | Oppenheimer | $75 | 325.9% upside | |
| 2025-12-17 | Cantor Fitzgerald | $74 | 320.2% upside | |
| 2025-12-12 | Morgan Stanley | $50 | 183.9% upside | |
| 2025-12-08 | RBC CapitalLeonid Timashev | $74 | 320.2% upside | |
| 2025-12-08 | UBSAshwani Verma | $48 | 172.6% upside | |
| 2025-10-17 | Johnson Rice | $60 | 240.7% upside | |
| 2025-07-02 | UBSAshwani Verma | $54 | 206.6% upside | |
| 2025-03-12 | H.C. WainwrightMitchell Kapoor | $75 | 325.9% upside | |
| 2024-11-13 | Cantor FitzgeraldRick Bienkowski | $83 | 371.3% upside | |
| 2024-10-15 | BTIGJustin Zelin | $91 | 416.8% upside | |
| 2024-10-15 | Johnson RiceGena Wang | $94 | 433.8% upside | |
| 2024-10-15 | BarclaysGena Wang | $94 | 433.8% upside | |
| 2024-10-08 | Redburn PartnersQize Ding | $86 | 388.4% upside | |
| 2024-06-17 | Piper SandlerEdward Tenthoff | $90 | 411.1% upside | |
| 2024-06-17 | Truist FinancialAsthika Goonewardene | $88 | 399.7% upside | |
| 2024-05-23 | Deutsche BankJames Shin | $60 | 240.7% upside | |
| 2024-05-17 | Morgan StanleyMatthew Harrison | $82 | 365.6% upside | |
| 2024-05-14 | RBC CapitalLeonid Timashev | $86 | 388.4% upside | |
| 2024-04-17 | ScotiabankGeorge Farmer | $65 | 269.1% upside | |
| 2024-04-03 | Cantor FitzgeraldRick Bienkowski | $82 | 365.6% upside | |
| 2024-03-14 | BMO CapitalKostas Biliouris | $90 | 411.1% upside | |
| 2022-12-06 | UBS | $66 | 274.8% upside | |